Purple Biotech
PPBT
15 hedge funds and large institutions have $306K invested in Purple Biotech in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 5 closing their positions.
7.3% more ownership
Funds ownership: 0.84% → 8.14% (+7.3%)
21% less funds holding
Funds holding: 19 → 15 (-4)
40% less capital invested
Capital invested by funds: $513K → $306K (-$208K)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
80% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
SmartHarvest Portfolios
Poulsbo,
Washington
|
+$72.2K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$34.7K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$49 |
| 4 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$102K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$28.1K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$1.76K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.14K |
| 5 |
GI
GAMMA Investing
Foster City,
California
|
-$950 |
PPBT Hedge Fund Activity: Q1 2026 in Review
15 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q1 2026, worth a combined $306K — down 40% from $513K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PPBT and 2 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 2 added.
The largest buyer was SmartHarvest Portfolios, adding an estimated $72.2K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $102K sold.
- 15 institutional investors held Purple Biotech (PPBT) as of Q1 2026, down from 19 in Q4 2025.
- Funds reported $306K of Purple Biotech stock for Q1 2026, down 40% quarter-over-quarter.
- 2 funds opened new Purple Biotech positions in Q1 2026 and 5 closed out, a net change of -3 holders.
- The largest Purple Biotech buyer in Q1 2026 was SmartHarvest Portfolios, an estimated $72.2K added.
- The largest Purple Biotech seller in Q1 2026 was Two Sigma Investments, an estimated $102K sold.
Based on aggregated 13F filings for Q1 2026.